Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology
- Supplementary File 1:
ZIP-Document (ZIP, 708 KiB)
Germain, A.; Ruppert, D.; Levine, S.M.; Hanson, M.R. Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology. Metabolites 2018, 8, 90. https://doi.org/10.3390/metabo8040090
Germain A, Ruppert D, Levine SM, Hanson MR. Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology. Metabolites. 2018; 8(4):90. https://doi.org/10.3390/metabo8040090
Chicago/Turabian StyleGermain, Arnaud, David Ruppert, Susan M. Levine, and Maureen R. Hanson. 2018. "Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology" Metabolites 8, no. 4: 90. https://doi.org/10.3390/metabo8040090


